SOUTHWEST ONCOLOGY GROUP S0221 FOLLOW UP FORM Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer Source Form: NCI FormBuilder:

  1. 8/26/12 8/26/12 -
  2. 3/20/14 3/20/14 - Martin Dugas
  3. 1/9/15 1/9/15 - Martin Dugas
Uploaded on:

January 9, 2015

To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Breast Cancer NCT00070564 Follow-Up - SOUTHWEST ONCOLOGY GROUP S0221 FOLLOW UP FORM - 2050216v3.0

No Instruction available.

    1. No Instruction available.
Administrative documentation
Vital Status
Vital Status
Disease Follow Up Status
Has the patient had a documented clinical assessment for this cancer since submission of the previous follow-up form?
Notice Of Progression - Adjuvant
Has the patient developed a first relapse or progression that has not been previously reported
Notice Of New Primary
Has a new primary cancer, opposite breast cancer, or myelodysplastic syndrome (MDS) been diagnosed that has not been previously reported?
Non-protocol Treatment
Has the patient received any non-protocol cancer therapy (prior to progression/relapse) not previously reported?
Long Term Toxicity
Has the patient experienced any severe long term toxicity that has not been previously reported?

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial